TABLE 2.

Differences in Vaginal Histology and TFV PK Endpoints Among PRE Women in the FOL (n = 20) and LUT (n = 20) Phase Combined Versus POST Women (n = 17) at Baseline Versus POST Women After Approximately 2 Months of Topical E2 Therapy